United States News Todas as matérias

Satellos Bioscience (NASDAQ:MSLE) said the U.S. Food and Drug Administration has granted Fast Track designation to SAT-3247 for the treatment of Duchenne muscular dystrophy.

Palvella Therapeutics (NASDAQ:PVLA) said it has submitted the first module of a rolling New Drug Application to the U.S. Food and Drug Administration for QTORIN 3.9% rapamycin gel.

iHuman (NYSE:IH) reported first-quarter 2026 revenue of RMB182.5 million, compared with RMB210.4 million in the same period last year, showing a year-over-year decline.

Comcast (NASDAQ:CMCSA) said it will divide its operations into two standalone public companies, separating its media assets from its connectivity and technology businesses through a tax-free spin-off.

BrainsWay (NASDAQ:BWAY) reported positive real-world data from what it described as the largest analysis of Deep Transcranial Magnetic Stimulation in patients with comorbid post-traumatic stress disorder and major depressive disorder.

Zentek (NASDAQ:ZTEK) said it has secured a pathway to sell its ZenGUARD enhanced air filtration media in the United States through an exclusive eight-year licensing agreement with Applied Silver.

Roadzen (NASDAQ:RDZN) reported its best quarter and fiscal year with fourth quarter revenue of $16.1 million, up 42% year over year and 12% sequentially.

Tonix Pharmaceuticals (NASDAQ:TNXP) said it enrolled the first patient in HORIZON, a Phase 2, randomized, double-blind, placebo-controlled study of TNX-102 SL 5.6 mg for adults with major depressive disorder.

HP (NYSE:HPQ) announced a strategic partnership with OpenAI to deploy its Frontier enterprise AI platform across HP’s global business operations.

Artivion (NYSE:AORT) announced that the U.S. Food and Drug Administration has granted premarket approval for its AMDS Hybrid Prosthesis for the treatment of acute DeBakey Type I aortic dissections with malperfusion.

Helus Pharma (NASDAQ:HELP) reported fiscal 2026 results with cash of $157.3 million as of March 31, 2026.

Neurogene (NASDAQ:NGNE) reported updated Phase 1/2 clinical data showing 47 total developmental milestone gains across 10 participants treated with NGN-401 gene therapy for Rett syndrome.

Martin Marietta (NYSE:MLM) said it will combine with Lhoist North America in a transaction valued at about $13.5 billion, structured as a mix of cash and stock consideration.

Rocket Lab (NASDAQ:RKLB) agreed to acquire Iridium (NASDAQ:IRDM) in a transaction valuing the combined deal at about $8 billion enterprise value, combining cash, stock, and structured consideration for shareholders.

Talawar Therapeutics and JATT II (NASDAQ:JATT) have entered into a definitive business combination agreement to create a Nasdaq-listed biotechnology company expected to trade as TLWR in the second half of 2026.

FTAI Infrastructure (NASDAQ:FIP) announced the completion of its acquisition of Tidewater Logistics, a barge and rail transloading company operating in Ohio, West Virginia, and Texas.

Diana Shipping (NYSE:DSX) extended its tender offer for all outstanding shares of Genco Shipping & Trading (NYSE:GNK) it does not already own to July 10, 2026 at 5:00 p.m. ET.

Larimar Therapeutics (NASDAQ:LRMR) announced the submission of the first module of a rolling Biologics License Application to the U.S. Food and Drug Administration seeking accelerated approval of nomlabofusp for the treatment of Friedreich’s ataxia.

Honeywell Technologies (NASDAQ:HON) completed the spin-off of its Aerospace Technologies business, which is now trading independently as Honeywell Aerospace (NASDAQ:HONA).

United Therapeutics (NASDAQ:UTHR) announced that the U.S. Food and Drug Administration has granted premarket approval of the LungFX device for use in centralized ex vivo lung perfusion.

Vertical Aerospace (NYSE:EVTL) announced a long-term agreement with Astronics Corporation (NASDAQ:ATRO) to supply the low-voltage power distribution system for its Valo electric vertical take-off and landing aircraft.

Constellium (NYSE:CSTM) announced the sale of its ownership stake in an automotive structures joint venture in Changchun, China, to a Chinese automotive holding company.

Korn Ferry (NYSE:KFY) has entered into a definitive agreement to acquire UK-headquartered AMS, creating a global leader in talent and organizational consulting.

Zymeworks has agreed to acquire Theravance Biopharma (NASDAQ:TBPH) for $17 per share in cash.